Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 9, 2011, Pages 1715-1722

  Richieri, Raphaelle ^a,b   Boyer, Laurent ^b   Farisse, Jean ^a   Colavolpe, Cecile ^b,c   Mundler, Olivier ^b,c   Lancon, Christophe ^a,b   Guedj, Eric ^b,c  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b TIMONE HOSPITAL   (France)

^c Aix Marseille University   (France)

Author keywords

Cerebral blood flow (CBF); Depression; Repetitive transcranial magnetic stimulation (RTMS); Single photon emission computed tomography (SPECT); SPM

Indexed keywords

ANTIDEPRESSANT AGENT; CYSTEINE ETHYL ESTER TC 99M; MOOD STABILIZER;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIPOLAR DEPRESSION; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FRONTAL CORTEX; HUMAN; MAJOR DEPRESSION; MALE; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; UNCUS;

BRAIN; CEREBROVASCULAR CIRCULATION; CYSTEINE; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; ROC CURVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 80455164720     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1850-9     Document Type: Article

References (41)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. World Health Organization. The world health report. Health systems: improving performance. Geneva: World Health Organization; 2000. p. 2000.
3. Baldwin RC, Simpson S. Treatment resistant depression in the elderly: A review of its conceptualisation, management and relationship to organic brain disease. J Affect Disord 1997;46(3):163-73. (Pubitemid 28165941)
4. McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, et al. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: A multicentre pragmatic randomised controlled trial and economic analysis. Health Technol Assess 2007;11(24):1-54.
5. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. Lancet 2003;361(9360):799-808.
6. Rose D, Fleischmann P, Wykes T, Leese M, Bindman J. Patients' perspectives on electroconvulsive therapy: systematic review. BMJ 2003;326(7403):1363.
7. Avery DH, Holtzheimer 3rd PE, Fawaz W, Russo J, Neumaier J, Dunner DL, et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry 2006;59(2):187-94. (Pubitemid 43117509)
8. Avery DH, Isenberg KE, Sampson SM, Janicak PG, Lisanby SH, Maixner DF, et al. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry 2008;69(3):441-51. (Pubitemid 351549398)
9. George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A shamcontrolled randomized trial. Arch Gen Psychiatry 2010;67(5):507-16.
10. Holtzheimer 3rd PE, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G, et al. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety 2010;27(10):960-3.
11. Grunhaus L, Schreiber S, Dolberg OT, Polak D, Dannon PN. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry 2003;53(4):324-31. (Pubitemid 36175546)
12. Eranti S, Mogg A, Pluck G, Landau S, Purvis R, Brown RG, et al. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry 2007;164(1):73-81. (Pubitemid 46154785)
13. Fregni F, Marcolin MA, Myczkowski M, Amiaz R, Hasey G, Rumi DO, et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol 2006;9(6):641-54. (Pubitemid 46127397)
14. Kito S, Fujita K, Koga Y. Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression. Neuropsychobiology 2008;58(1):29-36.
15. Mottaghy FM, Keller CE, Gangitano M, Ly J, Thall M, Parker JA, et al. Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res 2002;115(1-2):1-14. (Pubitemid 34880095)
16. Nadeau SE, McCoy KJ, Crucian GP, Greer RA, Rossi F, Bowers D, et al. Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability. Neuropsychiatry Neuropsychol Behav Neurol 2002;15(3):159-75. (Pubitemid 35006771)
17. Pizzagalli DA. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011;36(1):183-206.
18. Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, et al. Limbic-frontal circuitry in major depression: A path modeling metanalysis. Neuroimage 2004;22(1):409-18. (Pubitemid 38515850)
19. Spronk D, Arns M, Barnett KJ, Cooper NJ, Gordon E. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study. J Affect Disord 2011;128(1-2):41-8.
20. Teneback CC, Nahas Z, Speer AM, Molloy M, Stallings LE, Spicer KM, et al. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsychiatry Clin Neurosci 1999;11(4):426-35.
21. Declaration of Helsinki. Ethical principles for medical research involving human subjects. World Medical Association, General Assembly, Seoul, October 2008.
22. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56(6):893-7. (Pubitemid 19008360)
23. Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs AG. Manual for the state-trait anxiety inventory (form Y). Palo Alto: Consulting Psychologists Press; 1983.
24. George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995;6(14):1853-6.
25. Kennedy SH, Evans KR, Krüger S, Mayberg HS, Meyer JH, McCann S, et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001;158(6):899-905. (Pubitemid 32547619)
26. Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attar-Levy D, et al. Left prefrontal glucose hypometabolism in the depressed state: A confirmation. Am J Psychiatry 1990;147(10):1313-7. (Pubitemid 20346268)
27. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, et al. Cingulate function in depression: A potential predictor of treatment response. Neuroreport 1997;8(4):1057-61. (Pubitemid 27152174)
28. Brunelin J, Poulet E, Boeuve C, Zeroug-vial H, d'Amato T, Saoud M. Efficacy of repetitive transcranial magnetic stimulation (rTMS) in major depression: A review. Encephale 2007;33(2):126-34. (Pubitemid 46787702)
29. Langguth B, Wiegand R, Kharraz A, Landgrebe M, Marienhagen J, Frick U, et al. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS). Neuro Endocrinol Lett 2007;28(5):633-8.
30. Paus T, Barrett J. Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression. J Psychiatry Neurosci 2004;29(4):268-79. (Pubitemid 39179573)
31. Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry 2003;160(5):835-45. (Pubitemid 41079567)
32. Herwig U, Lampe Y, Juengling FD, Wunderlich A, Walter H, Spitzer M, et al. Add-on rTMS for treatment of depression: A pilot study using stereotaxic coil-navigation according to PET data. J Psychiatr Res 2003;37(4):267-75. (Pubitemid 36581943)
33. Kimbrell TA, Little JT, Dunn RT, Frye MA, Greenberg BD, Wassermann EM, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 1999;46(12):1603-13. (Pubitemid 30001602)
34. Ahdab R, Ayache SS, Brugières P, Goujon C, Lefaucheur JP Comparison of "standard" and "navigated" procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression. Neurophysiol Clin 2010;40(1):27-36.
35. Harel EV, Zangen A, Roth Y, Reti I, Braw Y Levkovitz Y H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility study. World J Biol Psychiatry 2011;12(2):119-26.
36. Dreyfus JF, Guelfi JD, Ruschel S, Blanchard C, Pichot P Factorial analysis of the Hamilton depression scale, II. Ann Med Psychol (Paris) 1981;139(4):446-53.
37. Guelfi JD, Dreyfus JF, Ruschel S, Blanchard C, Pichot P. Factorial structure of the Hamilton depression scale. I. Ann Med Psychol (Paris) 1981;139(2):199-214.
38. Peyre F, Martinez R, Calache M, Verdoux H, Bourgeois M. New validation of the Montgomery and Asberg Depression Scale (MADRS) on a sample of 147 hospitalized depressed patients. Ann Med Psychol (Paris) 1989;147(7):762-7. (Pubitemid 20002206)
39. Chambon O, Poncet F, Kiss L, Milani D, Cottraux J. French adaptation, concurrent validation and factorial analysis of the Bech and Rafaelsen melancholia scale. Encephale 1988;14(6):443-8. (Pubitemid 19031060)
40. Bouvard M, Charles S, Guérin J, Aimard G, Cottraux J. Study of Beck's hopelessness scale. Validation and factor analysis. Encephale 1992;18(3):237-40.
41. Collet L, Cottraux J. The shortened Beck depression inventory (13 items). Study of the concurrent validity with the Hamilton scale and Widlöcher's retardation scale. Encephale 1986;12(2):77-9. (Pubitemid 16083824)